TD Asset Management
GTHX

TD Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

TD Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,418
Closed -$208K – 1519
2021
Q4 		$208K Buy
20,418
+10,209
+100% +$130K ﹤0.01% 1453
2021
Q3 		$137K Hold
10,209
– – ﹤0.01% 1497
2021
Q2 		$177K Sell
10,209
-19,872
-66% -$441K ﹤0.01% 1488
2021
Q1 		$724K Buy
30,081
+1,239
+4% +$28.8K ﹤0.01% 1326
2020
Q4 		$519K Hold
28,842
– – ﹤0.01% 1327
2020
Q3 		$333K Hold
28,842
– – ﹤0.01% 1305
2020
Q2 		$700K Buy
28,842
+1,900
+7% +$31.4K ﹤0.01% 1145
2020
Q1 		$297K Sell
26,942
-8,800
-25% -$164K ﹤0.01% 1269
2019
Q4 		$945K Sell
35,742
-5,600
-14% -$131K ﹤0.01% 1109
2019
Q3 		$942K Buy
41,342
+8,392
+25% +$265K ﹤0.01% 1064
2019
Q2 		$1.01M Sell
32,950
-9,941
-23% -$209K ﹤0.01% 1050
2019
Q1 		$712K Buy
42,891
+400
+0.9% +$7.59K ﹤0.01% 1105
2018
Q4 		$814K Sell
42,491
-4,252
-9% -$159K ﹤0.01% 1106
2018
Q3 		$2.44M Buy
46,743
+14,075
+43% +$768K ﹤0.01% 941
2018
Q2 		$1.42M Buy
32,668
+6,832
+26% +$293K ﹤0.01% 1043
2018
Q1 		$957K Buy
+25,836
New +$689K ﹤0.01% 1075

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TD Asset Management's GTHX Position: Q1 2022 in Review

TD Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2022, closing a stake of 20,418 shares — an estimated $208K sold.

TD Asset Management first reported a position in GTHX in Q1 2018 and held it in 16 quarters. The position peaked at $2.44M in Q3 2018. 115 funds tracked by Wall St. Rank hold GTHX as of Q1 2022.

  • TD Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • TD Asset Management sold 20,418 G1 Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $208K.
  • TD Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • TD Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $2.44M in Q3 2018.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2022.

Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.